Latest Escitalopram Stories

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine. Compared with those receiving placebo, people who took the antidepressant escitalopram (sold as Lexapro) were more than two-and-a-half times less likely to have mental stress-induced myocardial ischemia (MSIMI), a heart condition brought on by mental stress. The findings, published in the May 22/29, 2013...

Lawyers will update judge about consolidated federal litigation involving hundreds of lawsuits claiming SSRI anti-depressant use allegedly caused birth defects. Free consultations about legal options are now available to consumers. San Diego, CA (PRWEB) May 17, 2013 http://www.resource4thepeople.com/defectivedrugs/zoloft.html Resource4thePeople today announced it is providing consumers its latest update about consolidated federal lawsuits* involving allegations that the use of Zoloft or...

LONDON, February 15, 2013 /PRNewswire/ -- Last year saw the expiration of patents for several blockbuster drugs,leading to increasing generic competition. The trend is expected to continue in 2013,with patents on a number of blockbuster drugs set to expire. For drug manufacturers,intensifying generic competition is a major concern. Meanwhile,companies such as Amarin Corporation Plc (ADR) (NASDAQ: AMRN) and Forest Laboratories Inc. (NYSE: FRX) are also assessing the impact of...

Legal advice offered while judge overseeing consolidated federal cases moves toward selecting bellwether cases San Diego CA (PRWEB) February 13, 2013 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today that it is providing referrals to free consultations with attorneys for victims who may have suffered serious side effects from the use of Zoloft and other anti-depressants classified as selective serotonin reuptake inhibitors...

MUMBAI, India and BALTIMORE, Maryland, September 13, 2012 /PRNewswire/ -- Pharma major, Lupin Ltd., announced today that its subsidiary Lupin Pharmaceuticals Inc. (collectively, Lupin) has received final approval for its Escitalopram Tablets (Escitalopram oxalate) 5 mg, 10 mg, and 20 mg, from the United States Food and Drugs Administration (FDA) to market a generic version of Forest Laboratories, Inc.'s (Forest) Lexapro Tablets, 5 mg, 10 mg, and 20 mg. Lupin's...

NEW YORK, Aug. 21, 2012 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released second quarter 2012 U.S. prescription sales data for the top 100 drugs. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top-selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year's end. Top Five Drugs...

Muscle-building supplement vastly improves response time, quality of recovery Women battling stubborn major depression may have a surprising new ally in their fight—the muscle-building dietary supplement creatine. In a new proof-of-concept study, researchers from three South Korean universities and the University of Utah report that women with major depressive disorder (MDD) who augmented their daily antidepressant with 5 grams of creatine responded twice as fast and experienced...

NEW YORK, July 24, 2012 /PRNewswire/ -- Carl Icahn today issued the following open letter to shareholders of Forest Laboratories, Inc.: CARL C. ICAHN767 Fifth Avenue, 47(th) FloorNew York, NY 10153 July 24, 2012 Dear Fellow Forest Labs Shareholders, The Forest Labs Annual Meeting will take place on August 15, 2012. Today we mailed you our definitive proxy statement containing important information, including information on how to vote your Forest shares. Your vote is important...

A new study, published in a recent edition of the journal Menopause, has discovered that combining massage with aromatherapy can be an effective way in reducing the symptoms of menopause. The study, which was conducted by researchers at Tehran University of Medical Sciences and is included in the April 30 of the journal, looked at treatments received by 90 women who entered a "menopausal clinic" at a women's hospital in the Iranian capital, Reuters reporter Amy Norton wrote on Friday....

NEW YORK, May 8, 2012 /PRNewswire/ -- According to the inaugural Harris Poll Physician Pulse(SM) study of American physicians' prescribing behaviors and influences, Viagra® and Cialis® are the top-ranked pharmaceutical treatments in terms of trust. In fact, the three erectile dysfunction (ED) brands, also including Levitra®, received some of the highest scores across all of the following categories surveyed: Anti-depressants (ADP); Anti-psychotics (APS); Erectile Dysfunction...